Login / Signup

Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.

Natalia SzejkoKamila SaramakAdam LombrosoKirsten Müller-Vahl
Published in: Neurologia i neurochirurgia polska (2021)
Increasing evidence suggests that CBM is efficacious in the treatment of tics and psychiatric comorbidities in patients with GTS. The results of ongoing larger RCTs, such as CANNA-TICS (ClinicalTrials.gov Identifier: NCT03087201), will further clarify the role of CBM in the treatment of patients with GTS.
Keyphrases
  • mental health
  • combination therapy